Breast Cancer Clinical Trials

Showing 3801-3820 of 5,597 trials

TCHP Versus EC -THP as Neoadjuvant Treatment for HER2-Positive Breast Cancer

NCT04094896

This study is to evaluate the efficacy and safety ofTCHP (docetaxel/carboplatin/trastuzumab/Pertuzumab) and EC followed by THP(epirubicin/cyclophosphamide followed by docetaxe plus trastuzumab/Pertuzumab)regimens as Neoadjuvant Treatment in HER2- Positive breast cancer. The endpoint of pathologic complete response is used as a surrogate marker for survival. Safety and tolerability assessed by number of grade 4 toxicities and hospitalizations.

HER2-Positive Breast Cancer

Guangdong Provincial People's Hospital200 participantsStarted Sep 2019

Guangzhou, China

COMPLETEDNA

LLLT Combined With CDT in Breast Cancer-Related Lymphedema

NCT01351376

This study aims to explore the effects of Low Level Laser Therapy (LLLT) on breast cancer-related lymphedema when utilized in conjunction with Complex Decongestive Therapy (CDT) when compared to CDT treatment alone. The investigators hypothesize that the addition of LLLT to CDT will result in statistically significant improvements and greater long-term benefits as measured by changes in arm volume and quality of life when compared to the benefits of CDT alone for the treatment of breast cancer-related lymphedema.

Breast CancerLymphedema

NYU Langone Health21 participantsStarted May 2011

New York, New York, United States • New York, New York, United States • New York, New York, United States

TCHP Versus EC -THP as Neoadjuvant Treatment for HER2-Positive Breast Cancer

LLLT Combined With CDT in Breast Cancer-Related Lymphedema

Related Searches

A Study of Subcutaneous At Home Administration of Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2-positive (HER2+) Early Breast Cancer (eBC)

Psyhosomatic Medicine in Oncologic and Cardiac Disease Study

Cabergoline in Metastatic Breast Cancer

Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer

Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer

Preoperative Accelerated Partial Breast Irradiation (APBI) for Women With Stage I and Select IIA Breast Cancer

Combination of Cryosurgery and NK Immunotherapy for Advanced Breast Cancer

The Prone Breast Radiation Therapy Trial

Recurrence Score-guiding Chemotherapy in Non-pCR HR Positive HER2 Negative Breast Cancer After Neoadjuvant Therapy

Optimizing Decision Making About Breast Reconstruction After Mastectomy: A Patient-Centered Approach

Computed Tomography (CT) Reconstruction for Axillary Lymph Node Structure

The Breast Cancer Personalized Nutrition Study

Randomized Trial Standard of Care Vascular Access Strategies for (Neo)Adjuvant Trastuzumab-based Breast Cancer Treatment.

A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer

Health Benefits of Expressive Writing Among Chinese Breast Cancer Survivors

Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer.

Health Benefits of Expressive Writing: Study One

Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer